| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Ovary Syndrome | 50 | 2021 | 203 | 10.000 |
Why?
|
| Hyperandrogenism | 20 | 2016 | 42 | 4.420 |
Why?
|
| Puberty | 31 | 2013 | 59 | 4.000 |
Why?
|
| Androgens | 49 | 2021 | 167 | 3.670 |
Why?
|
| Puberty, Precocious | 24 | 2021 | 36 | 3.110 |
Why?
|
| Hirsutism | 31 | 2018 | 61 | 3.040 |
Why?
|
| Ovary | 35 | 2017 | 258 | 2.780 |
Why?
|
| Testosterone | 77 | 2017 | 271 | 2.600 |
Why?
|
| Gonadotropin-Releasing Hormone | 22 | 2013 | 103 | 2.280 |
Why?
|
| Luteinizing Hormone | 49 | 2013 | 167 | 2.200 |
Why?
|
| Sebaceous Glands | 15 | 2007 | 28 | 2.120 |
Why?
|
| Turner Syndrome | 16 | 2018 | 27 | 1.840 |
Why?
|
| Adrenal Hyperplasia, Congenital | 15 | 2021 | 25 | 1.770 |
Why?
|
| Estradiol | 26 | 2017 | 252 | 1.550 |
Why?
|
| Gonadotropins | 13 | 2012 | 34 | 1.520 |
Why?
|
| Anovulation | 5 | 2015 | 10 | 1.320 |
Why?
|
| Adolescent | 95 | 2020 | 8981 | 1.300 |
Why?
|
| Nafarelin | 20 | 2009 | 43 | 1.250 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2020 | 10 | 1.220 |
Why?
|
| Female | 175 | 2021 | 44532 | 1.210 |
Why?
|
| Body Height | 16 | 2011 | 99 | 1.160 |
Why?
|
| Hypogonadism | 14 | 2010 | 37 | 1.100 |
Why?
|
| Follicle Stimulating Hormone | 36 | 2013 | 147 | 1.100 |
Why?
|
| Hormones | 8 | 2011 | 141 | 1.100 |
Why?
|
| Menstruation Disturbances | 9 | 2020 | 24 | 1.080 |
Why?
|
| Ovarian Diseases | 8 | 2015 | 32 | 1.010 |
Why?
|
| Child | 64 | 2021 | 6927 | 1.000 |
Why?
|
| Adrenocorticotropic Hormone | 21 | 2011 | 131 | 0.990 |
Why?
|
| Humans | 206 | 2021 | 86643 | 0.960 |
Why?
|
| Adrenarche | 2 | 2021 | 2 | 0.920 |
Why?
|
| Diagnostic Techniques, Endocrine | 2 | 2013 | 7 | 0.910 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 2 | 2020 | 6 | 0.890 |
Why?
|
| Hyperinsulinism | 7 | 2016 | 51 | 0.880 |
Why?
|
| Dexamethasone | 26 | 2011 | 326 | 0.880 |
Why?
|
| Insulin Resistance | 9 | 2016 | 377 | 0.880 |
Why?
|
| Pituitary Gland | 8 | 2013 | 117 | 0.880 |
Why?
|
| Obesity | 9 | 2010 | 963 | 0.820 |
Why?
|
| Puberty, Delayed | 10 | 2006 | 19 | 0.820 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 5 | 2009 | 11 | 0.810 |
Why?
|
| Body Mass Index | 7 | 2013 | 770 | 0.780 |
Why?
|
| Sexual Maturation | 4 | 2017 | 35 | 0.770 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2020 | 73 | 0.770 |
Why?
|
| Growth Disorders | 10 | 2011 | 63 | 0.770 |
Why?
|
| Growth Hormone | 11 | 2005 | 97 | 0.740 |
Why?
|
| Human Growth Hormone | 5 | 2011 | 54 | 0.740 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 14 | 2014 | 31 | 0.740 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 141 | 0.730 |
Why?
|
| Leuprolide | 6 | 2010 | 30 | 0.730 |
Why?
|
| Overweight | 3 | 2012 | 118 | 0.730 |
Why?
|
| Adrenal Glands | 14 | 2011 | 76 | 0.720 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 7 | 2003 | 122 | 0.720 |
Why?
|
| Sleep | 5 | 2013 | 444 | 0.690 |
Why?
|
| Growth | 8 | 2011 | 43 | 0.650 |
Why?
|
| Hair Removal | 1 | 2018 | 14 | 0.650 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2018 | 45 | 0.640 |
Why?
|
| Ovotesticular Disorders of Sex Development | 1 | 2017 | 4 | 0.600 |
Why?
|
| Somatomedins | 9 | 1999 | 28 | 0.600 |
Why?
|
| Hair Follicle | 4 | 2007 | 26 | 0.590 |
Why?
|
| Transcription Factors | 9 | 2009 | 1565 | 0.550 |
Why?
|
| Thiazolidinediones | 4 | 2001 | 82 | 0.550 |
Why?
|
| Hair | 8 | 2005 | 56 | 0.540 |
Why?
|
| Acne Vulgaris | 9 | 2000 | 32 | 0.540 |
Why?
|
| Polysomnography | 2 | 2013 | 151 | 0.540 |
Why?
|
| Endocrine System Diseases | 2 | 2015 | 23 | 0.530 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 45 | 0.510 |
Why?
|
| Community Networks | 1 | 2015 | 29 | 0.510 |
Why?
|
| Adult | 78 | 2017 | 25648 | 0.510 |
Why?
|
| Ethinyl Estradiol | 4 | 2011 | 16 | 0.480 |
Why?
|
| Menstrual Cycle | 2 | 2013 | 55 | 0.470 |
Why?
|
| Gonads | 2 | 2011 | 19 | 0.470 |
Why?
|
| Hypothalamus | 2 | 2011 | 79 | 0.460 |
Why?
|
| Male | 96 | 2017 | 40965 | 0.460 |
Why?
|
| Insulin-Like Growth Factor I | 11 | 2005 | 114 | 0.460 |
Why?
|
| Child, Preschool | 25 | 2021 | 3612 | 0.440 |
Why?
|
| Estrogens | 14 | 2018 | 200 | 0.440 |
Why?
|
| Chorionic Gonadotropin | 12 | 2009 | 72 | 0.440 |
Why?
|
| Menarche | 3 | 2009 | 24 | 0.430 |
Why?
|
| Testis | 9 | 2017 | 152 | 0.430 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2009 | 50 | 0.400 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2010 | 4 | 0.390 |
Why?
|
| Quality Improvement | 1 | 2015 | 428 | 0.390 |
Why?
|
| Cell Differentiation | 7 | 2002 | 1458 | 0.390 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2001 | 45 | 0.390 |
Why?
|
| Signal Transduction | 2 | 2020 | 3241 | 0.380 |
Why?
|
| Theca Cells | 6 | 2009 | 12 | 0.380 |
Why?
|
| Sebum | 3 | 2000 | 6 | 0.380 |
Why?
|
| Androgen Antagonists | 4 | 2018 | 144 | 0.370 |
Why?
|
| Alopecia | 4 | 2003 | 34 | 0.370 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 3 | 2011 | 18 | 0.360 |
Why?
|
| Rats | 22 | 2009 | 3990 | 0.360 |
Why?
|
| Cell Division | 6 | 2002 | 696 | 0.350 |
Why?
|
| Skin | 7 | 2007 | 554 | 0.350 |
Why?
|
| Dehydroepiandrosterone | 24 | 2000 | 51 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1036 | 0.350 |
Why?
|
| Mutation, Missense | 1 | 2010 | 276 | 0.340 |
Why?
|
| Glucose Tolerance Test | 8 | 2015 | 228 | 0.330 |
Why?
|
| Isoenzymes | 3 | 2001 | 271 | 0.330 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 1565 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 214 | 0.310 |
Why?
|
| Phenotype | 7 | 2014 | 2378 | 0.310 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 8 | 2009 | 22 | 0.300 |
Why?
|
| Age of Onset | 2 | 2015 | 310 | 0.300 |
Why?
|
| Insulin | 12 | 2020 | 1160 | 0.300 |
Why?
|
| Research Subjects | 1 | 2008 | 73 | 0.300 |
Why?
|
| Skin Physiological Phenomena | 1 | 2007 | 27 | 0.300 |
Why?
|
| Aging | 4 | 2010 | 691 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2008 | 125 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2010 | 1961 | 0.290 |
Why?
|
| Hormone Replacement Therapy | 2 | 2011 | 77 | 0.280 |
Why?
|
| Steroids | 5 | 2009 | 177 | 0.280 |
Why?
|
| Animals | 29 | 2016 | 26582 | 0.260 |
Why?
|
| Plicamycin | 1 | 2005 | 9 | 0.260 |
Why?
|
| Hydrocortisone | 8 | 2002 | 298 | 0.260 |
Why?
|
| Cells, Cultured | 13 | 2009 | 2818 | 0.260 |
Why?
|
| Polymorphism, Genetic | 5 | 2005 | 819 | 0.260 |
Why?
|
| Glucocorticoids | 5 | 2003 | 352 | 0.260 |
Why?
|
| Fetal Growth Retardation | 2 | 2008 | 66 | 0.250 |
Why?
|
| Menstruation | 7 | 2011 | 30 | 0.250 |
Why?
|
| Receptors, LH | 2 | 1996 | 7 | 0.240 |
Why?
|
| Age Determination by Skeleton | 7 | 2013 | 12 | 0.240 |
Why?
|
| Bartter Syndrome | 1 | 2003 | 3 | 0.240 |
Why?
|
| Complement C1q | 1 | 2003 | 10 | 0.240 |
Why?
|
| Immune Complex Diseases | 1 | 2003 | 19 | 0.230 |
Why?
|
| Contraceptives, Oral, Combined | 2 | 2018 | 8 | 0.230 |
Why?
|
| Biomedical Research | 1 | 2008 | 376 | 0.230 |
Why?
|
| Mutation | 7 | 2012 | 3968 | 0.230 |
Why?
|
| Hydroxyprogesterones | 8 | 1994 | 22 | 0.230 |
Why?
|
| Young Adult | 6 | 2015 | 5976 | 0.230 |
Why?
|
| Endocrine System | 1 | 2003 | 17 | 0.220 |
Why?
|
| Aneuploidy | 2 | 1999 | 55 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 937 | 0.220 |
Why?
|
| Receptors, Androgen | 3 | 2007 | 113 | 0.220 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 286 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2002 | 1219 | 0.210 |
Why?
|
| Dihydrotestosterone | 10 | 1999 | 27 | 0.210 |
Why?
|
| Epoprostenol | 1 | 2001 | 46 | 0.210 |
Why?
|
| Cyclic AMP | 2 | 2002 | 273 | 0.200 |
Why?
|
| Gene Expression | 3 | 2000 | 1284 | 0.200 |
Why?
|
| Adrenal Cortex Hormones | 4 | 1996 | 263 | 0.190 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1999 | 76 | 0.190 |
Why?
|
| Hyperhidrosis | 1 | 2000 | 10 | 0.180 |
Why?
|
| Research Design | 2 | 2015 | 594 | 0.180 |
Why?
|
| Premenopause | 2 | 2018 | 54 | 0.180 |
Why?
|
| Kidney Diseases | 1 | 2003 | 418 | 0.170 |
Why?
|
| Androstenedione | 12 | 2000 | 29 | 0.170 |
Why?
|
| Genitalia, Female | 3 | 1997 | 25 | 0.170 |
Why?
|
| Osmolar Concentration | 3 | 2012 | 181 | 0.170 |
Why?
|
| Dehydroepiandrosterone Sulfate | 7 | 2009 | 16 | 0.160 |
Why?
|
| Inhibins | 3 | 2009 | 37 | 0.160 |
Why?
|
| Thiazoles | 4 | 2001 | 131 | 0.160 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 1997 | 9 | 0.160 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1996 | 44 | 0.160 |
Why?
|
| Ovarian Function Tests | 3 | 2000 | 8 | 0.160 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 894 | 0.160 |
Why?
|
| Steroid Hydroxylases | 2 | 1990 | 14 | 0.160 |
Why?
|
| Genitalia, Male | 2 | 1997 | 24 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2018 | 378 | 0.160 |
Why?
|
| Drug Administration Schedule | 4 | 2010 | 916 | 0.160 |
Why?
|
| Pituitary Gland, Anterior | 3 | 1989 | 22 | 0.160 |
Why?
|
| Ovarian Follicle | 3 | 2009 | 72 | 0.160 |
Why?
|
| Genotype | 4 | 2010 | 1851 | 0.150 |
Why?
|
| Nuclear Family | 1 | 2017 | 92 | 0.150 |
Why?
|
| Child Development | 2 | 2011 | 163 | 0.150 |
Why?
|
| Chromosomes, Human, Y | 1 | 2017 | 22 | 0.150 |
Why?
|
| Fathers | 3 | 2008 | 70 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 429 | 0.150 |
Why?
|
| Granulosa Cells | 4 | 2009 | 32 | 0.150 |
Why?
|
| Mosaicism | 1 | 2017 | 67 | 0.150 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1996 | 6 | 0.140 |
Why?
|
| Ultrasonography | 5 | 2009 | 695 | 0.140 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 312 | 0.130 |
Why?
|
| Chromans | 3 | 2001 | 30 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2005 | 72 | 0.130 |
Why?
|
| Luciferases | 2 | 2005 | 118 | 0.130 |
Why?
|
| Adrenal Gland Diseases | 2 | 1994 | 13 | 0.130 |
Why?
|
| Reference Values | 6 | 2004 | 674 | 0.130 |
Why?
|
| Time Factors | 12 | 2007 | 5210 | 0.130 |
Why?
|
| Age Factors | 5 | 2018 | 1851 | 0.130 |
Why?
|
| Rare Diseases | 1 | 2015 | 59 | 0.130 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 35 | 0.130 |
Why?
|
| Prednisolone | 2 | 1992 | 41 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 162 | 0.120 |
Why?
|
| Amenorrhea | 4 | 1980 | 27 | 0.120 |
Why?
|
| Sex Hormone-Binding Globulin | 9 | 1988 | 20 | 0.120 |
Why?
|
| Transfection | 3 | 2005 | 896 | 0.120 |
Why?
|
| Organ Size | 2 | 2012 | 364 | 0.120 |
Why?
|
| 17-Ketosteroids | 8 | 1981 | 13 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2012 | 2767 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2012 | 1805 | 0.120 |
Why?
|
| Wakefulness | 2 | 2009 | 134 | 0.110 |
Why?
|
| Sex Characteristics | 5 | 2005 | 319 | 0.110 |
Why?
|
| Health | 1 | 2013 | 29 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2017 | 2379 | 0.110 |
Why?
|
| Algorithms | 2 | 2015 | 1830 | 0.110 |
Why?
|
| Drug Synergism | 3 | 2001 | 303 | 0.110 |
Why?
|
| Adiposity | 1 | 2012 | 70 | 0.110 |
Why?
|
| Base Sequence | 5 | 2009 | 2330 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1801 | 0.110 |
Why?
|
| Delayed-Action Preparations | 2 | 2005 | 116 | 0.110 |
Why?
|
| Heterozygote | 3 | 2011 | 365 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2015 | 3640 | 0.110 |
Why?
|
| Protein Binding | 15 | 1991 | 1456 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2011 | 4213 | 0.110 |
Why?
|
| Kinetics | 7 | 1997 | 1513 | 0.100 |
Why?
|
| Immunoassay | 3 | 1992 | 92 | 0.100 |
Why?
|
| Receptors, Cyclic AMP | 1 | 1991 | 2 | 0.100 |
Why?
|
| Gonadal Disorders | 1 | 2011 | 1 | 0.100 |
Why?
|
| Androstanes | 7 | 1972 | 7 | 0.100 |
Why?
|
| DNA Primers | 2 | 2005 | 543 | 0.100 |
Why?
|
| Adolescent Development | 1 | 2011 | 18 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 3030 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2011 | 596 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 1996 | 426 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2001 | 39 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 1621 | 0.100 |
Why?
|
| Hypotension | 1 | 2011 | 70 | 0.100 |
Why?
|
| Radioimmunoassay | 7 | 1995 | 155 | 0.100 |
Why?
|
| Dosage Forms | 1 | 2010 | 7 | 0.100 |
Why?
|
| Drug Costs | 1 | 2011 | 62 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2011 | 106 | 0.090 |
Why?
|
| Periodicity | 3 | 2010 | 119 | 0.090 |
Why?
|
| Hydroxysteroid Dehydrogenases | 5 | 2001 | 5 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1983 | 153 | 0.090 |
Why?
|
| Cushing Syndrome | 2 | 2007 | 24 | 0.090 |
Why?
|
| 17-alpha-Hydroxypregnenolone | 6 | 2000 | 12 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2001 | 1981 | 0.090 |
Why?
|
| Aldo-Keto Reductase Family 1 Member C3 | 2 | 2009 | 3 | 0.090 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 2 | 2009 | 6 | 0.090 |
Why?
|
| Breast | 3 | 2005 | 288 | 0.090 |
Why?
|
| Epithelial Cells | 3 | 2002 | 669 | 0.090 |
Why?
|
| Infertility, Female | 2 | 1983 | 93 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 93 | 0.080 |
Why?
|
| Pelvis | 1 | 2009 | 95 | 0.080 |
Why?
|
| Risk Factors | 3 | 2008 | 5417 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2009 | 196 | 0.080 |
Why?
|
| Pedigree | 4 | 1999 | 966 | 0.080 |
Why?
|
| Body Composition | 1 | 2009 | 68 | 0.080 |
Why?
|
| Models, Biological | 4 | 2006 | 1749 | 0.080 |
Why?
|
| Facies | 1 | 2008 | 27 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2009 | 114 | 0.080 |
Why?
|
| Cholera Toxin | 2 | 2002 | 21 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2000 | 393 | 0.080 |
Why?
|
| Government Regulation | 1 | 2008 | 49 | 0.080 |
Why?
|
| Blood Proteins | 2 | 1986 | 144 | 0.080 |
Why?
|
| Europe | 2 | 2006 | 309 | 0.080 |
Why?
|
| Adrenal Rest Tumor | 1 | 1987 | 1 | 0.080 |
Why?
|
| Conflict of Interest | 1 | 2008 | 67 | 0.080 |
Why?
|
| Body Weight | 1 | 2009 | 459 | 0.080 |
Why?
|
| Eccrine Glands | 1 | 2007 | 4 | 0.080 |
Why?
|
| Lipids | 2 | 2000 | 269 | 0.080 |
Why?
|
| Aromatase | 1 | 2007 | 12 | 0.080 |
Why?
|
| Pregnancy | 11 | 2002 | 2894 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 229 | 0.070 |
Why?
|
| Adrenal Cortex Diseases | 2 | 1997 | 6 | 0.070 |
Why?
|
| Leydig Cells | 4 | 1985 | 11 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2001 | 370 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2000 | 839 | 0.070 |
Why?
|
| Melanocytes | 1 | 2007 | 56 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2009 | 240 | 0.070 |
Why?
|
| Prognosis | 3 | 2010 | 3679 | 0.070 |
Why?
|
| Menotropins | 2 | 1983 | 21 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 123 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2008 | 195 | 0.070 |
Why?
|
| Hypertrichosis | 1 | 2005 | 4 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2007 | 143 | 0.070 |
Why?
|
| Tretinoin | 2 | 2000 | 126 | 0.070 |
Why?
|
| Anthropometry | 1 | 2006 | 74 | 0.070 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 62 | 0.070 |
Why?
|
| Education | 1 | 2006 | 58 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 147 | 0.070 |
Why?
|
| Ovarian Neoplasms | 2 | 1987 | 744 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 879 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1673 | 0.070 |
Why?
|
| Cosyntropin | 1 | 1985 | 5 | 0.070 |
Why?
|
| Sp3 Transcription Factor | 1 | 2005 | 2 | 0.070 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 16 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2005 | 19 | 0.070 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 31 | 0.070 |
Why?
|
| Adrenal Cortex | 5 | 1990 | 21 | 0.070 |
Why?
|
| Colforsin | 1 | 2005 | 74 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2007 | 166 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 268 | 0.060 |
Why?
|
| Inhibin-beta Subunits | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2009 | 173 | 0.060 |
Why?
|
| Activins | 1 | 2004 | 26 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2006 | 109 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2005 | 92 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 696 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 2000 | 503 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2005 | 351 | 0.060 |
Why?
|
| Endocrinology | 1 | 2006 | 66 | 0.060 |
Why?
|
| Progestins | 2 | 1980 | 22 | 0.060 |
Why?
|
| Leydig Cell Tumor | 2 | 1974 | 3 | 0.060 |
Why?
|
| Progesterone | 4 | 1994 | 110 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 503 | 0.060 |
Why?
|
| Serum Albumin | 3 | 1986 | 130 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2010 | 1351 | 0.060 |
Why?
|
| Glomerular Mesangium | 1 | 2003 | 23 | 0.060 |
Why?
|
| Anion Transport Proteins | 1 | 2003 | 10 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1991 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2003 | 42 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 782 | 0.060 |
Why?
|
| Parents | 1 | 2006 | 272 | 0.060 |
Why?
|
| Spermatogenesis | 3 | 1977 | 37 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2007 | 526 | 0.060 |
Why?
|
| Antibodies | 2 | 1997 | 350 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2003 | 29 | 0.060 |
Why?
|
| Melanoma | 1 | 2007 | 459 | 0.050 |
Why?
|
| Estradiol Congeners | 1 | 2002 | 8 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 1992 | 81 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 20 | 0.050 |
Why?
|
| Ovarian Cysts | 1 | 2002 | 17 | 0.050 |
Why?
|
| 17-Hydroxycorticosteroids | 3 | 1979 | 6 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 1997 | 1753 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 1999 | 1920 | 0.050 |
Why?
|
| Pediatrics | 1 | 2006 | 344 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 107 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2000 | 927 | 0.050 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 4 | 1990 | 9 | 0.050 |
Why?
|
| Infant | 6 | 2011 | 3046 | 0.050 |
Why?
|
| Progesterone Reductase | 1 | 1980 | 2 | 0.050 |
Why?
|
| Retinoids | 1 | 2000 | 17 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2001 | 270 | 0.050 |
Why?
|
| Culture Media | 2 | 1992 | 147 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 129 | 0.050 |
Why?
|
| Diethylstilbestrol | 2 | 1978 | 119 | 0.050 |
Why?
|
| Hypopituitarism | 3 | 1979 | 19 | 0.050 |
Why?
|
| Adapalene | 1 | 2000 | 1 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 135 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 1143 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 2 | 1992 | 64 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2006 | 2501 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 2261 | 0.050 |
Why?
|
| Middle Aged | 8 | 2012 | 25028 | 0.050 |
Why?
|
| Hypothyroidism | 5 | 2009 | 232 | 0.050 |
Why?
|
| Naphthalenes | 1 | 2000 | 45 | 0.050 |
Why?
|
| Prolactin | 2 | 1982 | 88 | 0.050 |
Why?
|
| Oligomenorrhea | 3 | 1992 | 11 | 0.050 |
Why?
|
| Androsterone | 2 | 1990 | 5 | 0.050 |
Why?
|
| Exons | 2 | 1999 | 450 | 0.040 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1999 | 33 | 0.040 |
Why?
|
| Dermatitis | 1 | 2000 | 32 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 1999 | 87 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 130 | 0.040 |
Why?
|
| Epidermis | 1 | 2000 | 100 | 0.040 |
Why?
|
| Homozygote | 1 | 1999 | 200 | 0.040 |
Why?
|
| Stem Cells | 1 | 2001 | 351 | 0.040 |
Why?
|
| Hydroxysteroids | 6 | 1983 | 11 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2426 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 1208 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 639 | 0.040 |
Why?
|
| Disorders of Sex Development | 2 | 1977 | 18 | 0.040 |
Why?
|
| Virilism | 2 | 1994 | 6 | 0.040 |
Why?
|
| Bone Development | 4 | 2004 | 34 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 1998 | 5 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 1999 | 96 | 0.040 |
Why?
|
| Oxandrolone | 1 | 1977 | 1 | 0.040 |
Why?
|
| Infertility, Male | 1 | 1978 | 24 | 0.040 |
Why?
|
| Serum Globulins | 3 | 1973 | 12 | 0.040 |
Why?
|
| Epididymis | 1 | 1997 | 18 | 0.040 |
Why?
|
| Cryptorchidism | 1 | 1977 | 11 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 243 | 0.040 |
Why?
|
| Adrenal Insufficiency | 2 | 1974 | 23 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1997 | 18 | 0.040 |
Why?
|
| Tritium | 7 | 1972 | 133 | 0.040 |
Why?
|
| Antioxidants | 1 | 1999 | 223 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 1997 | 129 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1997 | 256 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 8 | 1973 | 32 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 1999 | 1373 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 1014 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 1997 | 35 | 0.040 |
Why?
|
| Fluoxymesterone | 1 | 1977 | 2 | 0.040 |
Why?
|
| Sex Factors | 5 | 2009 | 1054 | 0.040 |
Why?
|
| Genes | 2 | 1997 | 305 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 98 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1196 | 0.040 |
Why?
|
| Fees, Medical | 1 | 1996 | 10 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 853 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1999 | 912 | 0.040 |
Why?
|
| Isomerases | 1 | 1975 | 9 | 0.030 |
Why?
|
| Estrus | 1 | 1975 | 43 | 0.030 |
Why?
|
| Sertoli Cell Tumor | 1 | 1974 | 2 | 0.030 |
Why?
|
| Metformin | 1 | 1997 | 128 | 0.030 |
Why?
|
| Insurance, Health | 1 | 1996 | 160 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2000 | 1924 | 0.030 |
Why?
|
| Cystadenoma | 1 | 1974 | 19 | 0.030 |
Why?
|
| Antithyroid Agents | 1 | 1974 | 20 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1994 | 245 | 0.030 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1974 | 30 | 0.030 |
Why?
|
| Perfusion | 2 | 1986 | 203 | 0.030 |
Why?
|
| Goiter | 1 | 1974 | 43 | 0.030 |
Why?
|
| Dialysis | 4 | 1981 | 24 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1994 | 92 | 0.030 |
Why?
|
| Keratins | 2 | 1992 | 63 | 0.030 |
Why?
|
| Pituitary Neoplasms | 1 | 1974 | 62 | 0.030 |
Why?
|
| Pubic Bone | 1 | 1994 | 9 | 0.030 |
Why?
|
| Prostate | 1 | 1997 | 378 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1994 | 88 | 0.030 |
Why?
|
| Congenital Hypothyroidism | 1 | 1974 | 79 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1974 | 111 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1993 | 117 | 0.030 |
Why?
|
| Syndrome | 3 | 2008 | 446 | 0.030 |
Why?
|
| United States | 1 | 2006 | 6672 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2007 | 29 | 0.030 |
Why?
|
| Diabetes Mellitus | 2 | 1999 | 806 | 0.030 |
Why?
|
| Methods | 6 | 1973 | 152 | 0.030 |
Why?
|
| Islets of Langerhans | 2 | 1993 | 544 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1994 | 679 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1988 | 145 | 0.030 |
Why?
|
| Mice | 2 | 2000 | 11352 | 0.030 |
Why?
|
| Liver | 1 | 1997 | 1230 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1992 | 94 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1991 | 31 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1991 | 64 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 1987 | 1019 | 0.030 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 1971 | 2 | 0.030 |
Why?
|
| Biological Assay | 4 | 1985 | 78 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 41 | 0.030 |
Why?
|
| Clomiphene | 3 | 1980 | 18 | 0.030 |
Why?
|
| Shock | 1 | 2011 | 42 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1974 | 336 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1988 | 268 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 279 | 0.020 |
Why?
|
| Pituitary Diseases | 1 | 1970 | 5 | 0.020 |
Why?
|
| Acromegaly | 1 | 1970 | 5 | 0.020 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1990 | 4 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 2271 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1972 | 105 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1990 | 56 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1977 | 2232 | 0.020 |
Why?
|
| Thyroid Hormones | 2 | 1988 | 321 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 339 | 0.020 |
Why?
|
| Blood Glucose | 6 | 1999 | 873 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1985 | 989 | 0.020 |
Why?
|
| Reproduction | 1 | 1991 | 195 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1989 | 112 | 0.020 |
Why?
|
| Glucose | 3 | 1997 | 638 | 0.020 |
Why?
|
| Ovulation Induction | 1 | 1989 | 33 | 0.020 |
Why?
|
| Cell Separation | 1 | 1989 | 196 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 1988 | 3 | 0.020 |
Why?
|
| Castration | 3 | 1977 | 41 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 1128 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1988 | 54 | 0.020 |
Why?
|
| Thyroid Crisis | 1 | 1988 | 3 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1988 | 332 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 378 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2008 | 71 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 280 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2008 | 114 | 0.020 |
Why?
|
| Bone Density | 1 | 2009 | 209 | 0.020 |
Why?
|
| Androstenediols | 3 | 1980 | 3 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 2008 | 1169 | 0.020 |
Why?
|
| Uterus | 1 | 2009 | 215 | 0.020 |
Why?
|
| Gonadotropins, Pituitary | 3 | 1977 | 11 | 0.020 |
Why?
|
| Kallmann Syndrome | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dwarfism, Pituitary | 1 | 1967 | 3 | 0.020 |
Why?
|
| Stimulation, Chemical | 3 | 1989 | 63 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 1967 | 65 | 0.020 |
Why?
|
| Sertoli Cells | 2 | 1977 | 18 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1986 | 141 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1988 | 339 | 0.020 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 1984 | 7 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1990 | 1135 | 0.020 |
Why?
|
| Ovulation | 3 | 1976 | 68 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 1376 | 0.020 |
Why?
|
| Linear Models | 1 | 2006 | 421 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 1985 | 60 | 0.020 |
Why?
|
| Testicular Diseases | 2 | 1977 | 8 | 0.020 |
Why?
|
| Reference Standards | 1 | 1985 | 159 | 0.020 |
Why?
|
| Etiocholanolone | 1 | 1984 | 5 | 0.020 |
Why?
|
| Genitalia | 1 | 1984 | 21 | 0.020 |
Why?
|
| Pregnanetriol | 2 | 1975 | 2 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2357 | 0.010 |
Why?
|
| Scalp | 1 | 1984 | 72 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1997 | 1074 | 0.010 |
Why?
|
| Carbon Isotopes | 3 | 1972 | 76 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1997 | 673 | 0.010 |
Why?
|
| Chromatography | 2 | 1972 | 28 | 0.010 |
Why?
|
| 20-Hydroxysteroid Dehydrogenases | 1 | 2001 | 1 | 0.010 |
Why?
|
| 20-alpha-Hydroxysteroid Dehydrogenase | 1 | 2001 | 1 | 0.010 |
Why?
|
| Thyrotropin | 3 | 1974 | 280 | 0.010 |
Why?
|
| Sulfates | 2 | 1972 | 56 | 0.010 |
Why?
|
| Oligospermia | 1 | 1980 | 4 | 0.010 |
Why?
|
| Data Collection | 1 | 2002 | 372 | 0.010 |
Why?
|
| Chromatography, Gas | 2 | 1969 | 28 | 0.010 |
Why?
|
| Menopause | 1 | 1979 | 71 | 0.010 |
Why?
|
| Pseudohypoparathyroidism | 1 | 1978 | 5 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 145 | 0.010 |
Why?
|
| DNA | 1 | 1984 | 1294 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1977 | 8 | 0.010 |
Why?
|
| Spermatids | 1 | 1977 | 5 | 0.010 |
Why?
|
| Aldosterone | 2 | 1975 | 65 | 0.010 |
Why?
|
| Klinefelter Syndrome | 1 | 1977 | 4 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1983 | 1621 | 0.010 |
Why?
|
| Binding Sites | 2 | 1971 | 1098 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 36 | 0.010 |
Why?
|
| Genital Diseases, Male | 1 | 1977 | 8 | 0.010 |
Why?
|
| Genital Diseases, Female | 1 | 1977 | 24 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 152 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 636 | 0.010 |
Why?
|
| Zinc | 1 | 1976 | 91 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1979 | 303 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1996 | 129 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 135 | 0.010 |
Why?
|
| Laparoscopy | 1 | 1983 | 754 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1996 | 143 | 0.010 |
Why?
|
| Spermatozoa | 2 | 1977 | 62 | 0.010 |
Why?
|
| Propionates | 1 | 1974 | 34 | 0.010 |
Why?
|
| Hydrolases | 1 | 1994 | 28 | 0.010 |
Why?
|
| Long-Acting Thyroid Stimulator | 1 | 1974 | 3 | 0.010 |
Why?
|
| Methimazole | 1 | 1974 | 13 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1974 | 24 | 0.010 |
Why?
|
| Prevalence | 1 | 1999 | 1239 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1999 | 535 | 0.010 |
Why?
|
| Clone Cells | 1 | 1974 | 213 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 39 | 0.010 |
Why?
|
| Twins | 1 | 1974 | 65 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1974 | 119 | 0.010 |
Why?
|
| Feedback | 2 | 1972 | 133 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 623 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1974 | 75 | 0.010 |
Why?
|
| Chicago | 1 | 1999 | 1379 | 0.010 |
Why?
|
| Germ Cells | 1 | 1974 | 126 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1973 | 13 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1974 | 134 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 80 | 0.010 |
Why?
|
| Estrone | 1 | 1973 | 10 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1973 | 13 | 0.010 |
Why?
|
| Androstenols | 1 | 1973 | 3 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1974 | 391 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1974 | 78 | 0.010 |
Why?
|
| Sodium | 1 | 1975 | 341 | 0.010 |
Why?
|
| Half-Life | 1 | 1973 | 96 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 1993 | 39 | 0.010 |
Why?
|
| Vagina | 1 | 1974 | 161 | 0.010 |
Why?
|
| Chromatography, Paper | 1 | 1972 | 11 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1972 | 16 | 0.010 |
Why?
|
| C-Peptide | 1 | 1993 | 174 | 0.010 |
Why?
|
| Androstenes | 1 | 1973 | 43 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1974 | 269 | 0.010 |
Why?
|
| Acetylation | 1 | 1972 | 121 | 0.010 |
Why?
|
| Thyroxine | 1 | 1974 | 344 | 0.010 |
Why?
|
| Luteal Phase | 2 | 1986 | 14 | 0.010 |
Why?
|
| Crystallization | 1 | 1972 | 206 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1972 | 29 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1974 | 996 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 28 | 0.010 |
Why?
|
| Asparagine | 1 | 1991 | 29 | 0.010 |
Why?
|
| Histidine | 1 | 1991 | 55 | 0.010 |
Why?
|
| Sulfuric Acids | 1 | 1971 | 6 | 0.010 |
Why?
|
| Gynecomastia | 1 | 1971 | 8 | 0.010 |
Why?
|
| Rheumatic Heart Disease | 1 | 1971 | 29 | 0.010 |
Why?
|
| Chemistry | 1 | 1971 | 54 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1971 | 34 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 126 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1971 | 72 | 0.010 |
Why?
|
| Aluminum | 1 | 1971 | 22 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1971 | 40 | 0.010 |
Why?
|
| Codon | 1 | 1991 | 124 | 0.010 |
Why?
|
| Esters | 1 | 1971 | 29 | 0.010 |
Why?
|
| Creatine | 1 | 1971 | 23 | 0.010 |
Why?
|
| Oxides | 1 | 1971 | 43 | 0.010 |
Why?
|
| Silicon Dioxide | 1 | 1971 | 39 | 0.010 |
Why?
|
| Adenoma, Chromophobe | 1 | 1970 | 3 | 0.010 |
Why?
|
| Nitrogen | 1 | 1971 | 70 | 0.010 |
Why?
|
| Phosphorus | 1 | 1971 | 118 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1991 | 498 | 0.010 |
Why?
|
| Follicular Phase | 2 | 1982 | 11 | 0.010 |
Why?
|
| Peptides | 1 | 1973 | 639 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1991 | 557 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1991 | 729 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 2062 | 0.000 |
Why?
|
| Pituitary Function Tests | 1 | 1967 | 3 | 0.000 |
Why?
|
| Metyrapone | 1 | 1967 | 3 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1988 | 256 | 0.000 |
Why?
|
| Karyotyping | 1 | 1967 | 250 | 0.000 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 13 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1967 | 107 | 0.000 |
Why?
|
| Aged | 2 | 1988 | 18415 | 0.000 |
Why?
|
| Levodopa | 1 | 1986 | 36 | 0.000 |
Why?
|
| DNA Replication | 1 | 1986 | 164 | 0.000 |
Why?
|
| Androgen-Binding Protein | 1 | 1982 | 7 | 0.000 |
Why?
|
| Mathematics | 1 | 1981 | 190 | 0.000 |
Why?
|
| Androstenediol | 1 | 1980 | 1 | 0.000 |
Why?
|
| Sperm Count | 1 | 1980 | 9 | 0.000 |
Why?
|
| Ethynodiol Diacetate | 1 | 1979 | 1 | 0.000 |
Why?
|
| Mestranol | 1 | 1979 | 4 | 0.000 |
Why?
|
| Diabetes Insipidus | 2 | 1971 | 17 | 0.000 |
Why?
|
| Glucagon | 1 | 1978 | 111 | 0.000 |
Why?
|
| Adenylyl Cyclases | 1 | 1978 | 100 | 0.000 |
Why?
|
| Semen | 1 | 1977 | 13 | 0.000 |
Why?
|
| Taste Threshold | 1 | 1976 | 4 | 0.000 |
Why?
|
| Cell Count | 1 | 1977 | 195 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1973 | 40 | 0.000 |
Why?
|
| Insulin Antibodies | 1 | 1973 | 2 | 0.000 |
Why?
|
| Mineralocorticoids | 1 | 1973 | 10 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1973 | 53 | 0.000 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1973 | 13 | 0.000 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1973 | 14 | 0.000 |
Why?
|
| Pigmentation Disorders | 1 | 1973 | 13 | 0.000 |
Why?
|
| Arginine | 1 | 1973 | 136 | 0.000 |
Why?
|
| Body Temperature | 1 | 1973 | 124 | 0.000 |
Why?
|
| Nausea | 1 | 1973 | 175 | 0.000 |
Why?
|
| Antigens | 1 | 1973 | 228 | 0.000 |
Why?
|
| Hyperglycemia | 1 | 1973 | 176 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1971 | 62 | 0.000 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1971 | 19 | 0.000 |
Why?
|
| Seizures | 1 | 1973 | 297 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1976 | 730 | 0.000 |
Why?
|
| Glucuronates | 1 | 1969 | 22 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1973 | 567 | 0.000 |
Why?
|
| Craniopharyngioma | 1 | 1967 | 11 | 0.000 |
Why?
|
| Down Syndrome | 1 | 1967 | 53 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1969 | 384 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1969 | 736 | 0.000 |
Why?
|